Smartphone App Boosts Medication for Opioid Use Disorder Outcomes
Smartphone App Boosts Opioid Treatment Success, Study Finds
Texas Study Shows Significant Reduction in Opioid Use and Improved Treatment Retention
A new study suggests that combining medication for opioid use disorder (MOUD) with a smartphone app-based contingency management (CM) program can significantly improve treatment outcomes. The research, published in JAMA Network Open, found that patients receiving MOUD plus CM through the WEconnect app reported a 30% reduction in opioid use days and a 23% betterment in treatment retention compared to those receiving MOUD alone.the retrospective cohort study analyzed data from opioid treatment programs and office-based opioid treatment programs across Texas between 2020 and 2023. Researchers used matched control sampling to create two groups of 300 uninsured or underinsured adults, ensuring similarity in age, sex, race, and ethnicity.”As a virtual treatment, app-based CM has fewer infrastructure barriers to implementation and should provide opportunities for rapid dissemination to patients,” the investigators wrote.
The study revealed a significant difference in outcomes between the two groups. Patients who chose MOUD plus app-based CM reported an average of 8.4 days of opioid use at the end of treatment, compared to 12.0 days for those receiving MOUD alone.
Treatment retention was also significantly higher in the MOUD plus app-based CM group, with an average duration of 290.2 days compared to 236.1 days in the MOUD-only group.
While the study highlights the potential of app-based CM to enhance opioid treatment, researchers acknowledge some limitations. Because CM was offered as part of standard clinical care, patients were not randomly assigned to treatment conditions, possibly introducing selection bias. Additionally, variations existed among clinicians in their effectiveness at introducing and engaging patients with the app.
Despite these limitations, the findings offer promising insights into innovative approaches to combatting the opioid epidemic. The study’s authors suggest that integrating recovery-oriented, app-based CM could be a valuable tool for improving clinical care and meeting the needs of underserved patients taking MOUD.